TD Asset Management Inc cut its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.1% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 399,641 shares of the financial services provider's stock after selling 12,910 shares during the period. TD Asset Management Inc owned approximately 0.11% of CME Group worth $106,021,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Heartland Bank & Trust Co acquired a new stake in CME Group during the 1st quarter worth approximately $377,000. Catalyst Capital Advisors LLC lifted its holdings in shares of CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock valued at $971,000 after acquiring an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. purchased a new stake in CME Group during the 1st quarter worth $367,000. Fulcrum Equity Management purchased a new stake in CME Group during the 1st quarter worth $258,000. Finally, Aspire Growth Partners LLC purchased a new position in CME Group in the fourth quarter valued at about $548,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several equities research analysts recently commented on the company. Barclays set a $298.00 target price on CME Group and gave the company an "equal weight" rating in a report on Thursday. Royal Bank Of Canada reiterated a "sector perform" rating and set a $269.00 price objective on shares of CME Group in a research note on Thursday, April 3rd. JPMorgan Chase & Co. decreased their price target on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Erste Group Bank downgraded CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Piper Sandler raised their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 15th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, CME Group currently has a consensus rating of "Hold" and an average price target of $261.93.
Check Out Our Latest Stock Analysis on CME
Insider Transactions at CME Group
In other CME Group news, Director William R. Shepard purchased 256 shares of the company's stock in a transaction that occurred on Wednesday, June 25th. The stock was purchased at an average price of $270.53 per share, with a total value of $69,255.68. Following the completion of the transaction, the director directly owned 258,196 shares of the company's stock, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of the stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the transaction, the director directly owned 3,108 shares of the company's stock, valued at $863,651.04. This trade represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 11,400 shares of company stock valued at $3,152,410 in the last three months. 0.30% of the stock is currently owned by company insiders.
CME Group Stock Down 1.9%
Shares of NASDAQ CME traded down $5.43 during mid-day trading on Monday, reaching $274.12. The company had a trading volume of 2,233,354 shares, compared to its average volume of 2,384,371. The stock has a market capitalization of $98.78 billion, a PE ratio of 26.54, a price-to-earnings-growth ratio of 4.96 and a beta of 0.44. CME Group Inc. has a twelve month low of $193.25 and a twelve month high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock's 50 day moving average is $276.44 and its 200-day moving average is $262.72.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The business's quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the business earned $2.56 EPS. As a group, equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio is presently 48.40%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.